Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03954964 · ClinicalTrials.gov registry record · NA

Increasing Awareness of Opioid Disposal in the Orthopedic Patient Population

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT03954964: Completed NA study, sponsored by Mayo Clinic.

NCT03954964 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03954964, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

Researchers are trying to determine if providing education on proper disposal of unused opioid medications to the orthopedic patient undergoing a planned hip or knee total joint replacement will increase the percentage of patients who properly dispose of unused opioids.

Primary Outcome

Number of subjects to self-report disposal of unused prescription pain medication on the twelve week post operative visit survey

Interventions

  • BEHAVIORAL Education on disposal of opioids

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2019-06-03
Est. Completion 2019-12-31
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT03954964 record still lists

NCT03954964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which Education on disposal of opioids is the first listed.

NCT03954964 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03954964 about?

NCT03954964 is a clinical study titled "Increasing Awareness of Opioid Disposal in the Orthopedic Patient Population". Researchers are trying to determine if providing education on proper disposal of unused opioid medications to the orthopedic patient undergoing a planned hip or knee total joint replacement will increase the percentage of patients who properly dispose of unused opioids.

What is the current status of trial NCT03954964?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2019-06-03. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT03954964?

The interventions under investigation include: Education on disposal of opioids (BEHAVIORAL).

Who is sponsoring clinical trial NCT03954964?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03954964's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03954964, the US trial registry maintained by the National Library of Medicine. NCT03954964 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.